Inventor · disambiguated record
Ronald R. Tuttle
Also filed as: TUTTLE RONALD R
29 granted patents·1,076 citations·filing 1975–2000
98Inventor score
Top patents by PatentIndex Score
29 records- 0195US5460605ADiagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonistGENSIA INC·Filed 1993·Granted Oct 24, 1995·115 cites·24 claims
- 0295US5286252ADiagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonistGENSIA PHARMA·Filed 1990·Granted Feb 15, 1994·110 cites·10 claims
- 0395US5108363ADiagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonistGENSIA PHARMA·Filed 1989·Granted Apr 28, 1992·75 cites·44 claims
- 0492US6534503B1Melanocortin receptor-3 ligands to treat sexual dysfunctionLION BIOSCIENCE AG·Filed 2000·Granted Mar 18, 2003·75 cites·71 claims
- 0592US3987200AMethod for increasing cardiac contractilityLILLY CO ELI·Filed 1975·Granted Oct 19, 1976·32 cites·8 claims
- 0691US5420109ACytokine restraining agentsHOUGHTEN PHARM INC·Filed 1993·Granted May 30, 1995·84 cites·24 claims
- 0789US5658889AMethod and compounds for aica riboside delivery and for lowering blood glucoseGENSIA PHARMA·Filed 1994·Granted Aug 19, 1997·109 cites·22 claims
- 0886US5786332ACytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levelsTREGA BIOSCIENCES INC·Filed 1995·Granted Jul 28, 1998·51 cites·46 claims
- 0986US5760001ACytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levelsTREGA BIOSCIENCES INC·Filed 1995·Granted Jun 2, 1998·52 cites·22 claims
- 1081US5726156ACytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levelsTREGA BIOSCIENCES INC·Filed 1995·Granted Mar 10, 1998·59 cites·31 claims
- 1181US5234404ADiagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonistGENSIA PHARMA·Filed 1991·Granted Aug 10, 1993·63 cites·19 claims
- 1279US6284735B1HP-3228 and related peptides to treat sexual dysfunctionLION BIOSCIENCE AG·Filed 1999·Granted Sep 4, 2001·35 cites·33 claims
- 1370US4774230AGlucuronic acid derivatives of opioid antagonistsIVAX LAB INC·Filed 1988·Granted Sep 27, 1988·25 cites·9 claims
- 1467US4562206AOrally effective inotropic compoundsKEY PHARMA·Filed 1984·Granted Dec 31, 1985·7 cites·12 claims
- 1565US4424209A3,4-Di-isobutyryloxy-N- 3-(4-isobutyryloxyphenyl)-1-methyl-n-propyl!-beta-phenethylamine cyclodextrin complexesKEY PHARMA·Filed 1982·Granted Jan 3, 1984·21 cites·4 claims
- 1664US5888969AUse of cytokine restraining agents to treat inflammatory bowel diseaseTREGA BIOSCIENCES INC·Filed 1997·Granted Mar 30, 1999·11 cites·13 claims
- 1763US6245738B1Cytokine restraining agentsTREGA BIOSCIENCES INC·Filed 1994·Granted Jun 12, 2001·21 cites·49 claims
- 1862US4425336A3,4-Dihydroxy-N-[3-(4-dihydroxyphenyl)-1-methyl-n-propyl]-beta-phenethylamine cyclodextrin complexesKEY PHARMA·Filed 1982·Granted Jan 10, 1984·19 cites·3 claims
- 1961US5965536AMethods of inhibiting CXC intercrine moleculesUNIV TEXAS·Filed 1993·Granted Oct 12, 1999·28 cites·59 claims
- 2058US5643967AGrowth promotionLILLY CO ELI·Filed 1993·Granted Jul 1, 1997·16 cites·38 claims
- 2154US4511570ASenile dementia treatmentKEY PHARMA·Filed 1983·Granted Apr 16, 1985·13 cites·4 claims
- 2251US5395970A1-(3,4-dihydroxyphenyl)-2-(4-(4-hydroxyphenyl)butaylamino)ethanolGENSIA PHARMA·Filed 1993·Granted Mar 7, 1995·5 cites·2 claims
- 2351US4946848AMethod of treating pruritus with nalmefene and clonidineBAKER CUMINS DERMATOLOGICALS I·Filed 1989·Granted Aug 7, 1990·24 cites·4 claims
- 2451US4454142AHyperkinetic child treatment agentKEY PHARMA·Filed 1983·Granted Jun 12, 1984·11 cites·4 claims
- 2549US4849453AGrowth promotionLILLY CO ELI·Filed 1988·Granted Jul 18, 1989·3 cites·2 claims
- 2645US5741774AUse of a cytokine regulatory agent to treat rheumatoid arthritisTREGA BIOSCIENCES INC·Filed 1996·Granted Apr 21, 1998·4 cites·15 claims
- 2736US5597843AUse of a substituted 1,3-benzodioxole to reduce a wasting conditionHOUGHTEN PHARMACEUTICALS·Filed 1995·Granted Jan 28, 1997·5 cites·10 claims
- 2834US4483860AHyperkinetic child treatment agentKEY PHARMA·Filed 1983·Granted Nov 20, 1984·2 cites·4 claims
- 2931US5888978AMethod for reducing the severity of gastro-intestinal damageTREGA BIOSCIENCES INC·Filed 1995·Granted Mar 30, 1999·1 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Ronald R. Tuttle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →